73-Year-Old PatientATM, INCREASING ctDNA MUTATIONS “Using plasma NGS in monitoring treatment response in pancreatic - and all - cancers can be notably impactful in helping patients live longer and live better. Plasma ctDNA can identify [...]

 56-Year-Old MaleBRCA SOMATIC RESULTS  “This case brings up two treatment decisions. What chemotherapy and what, if any, maintenance therapy?” - Dr. Paul Walker, Chief Medical Officer, Former Director of Thoracic Oncology at East Carolina University [...]

46-Year-Old FemaleATM GERMLINE AND ALK FUSION SOMATIC RESULTS “The germline ATM and somatic ALK fusion molecular findings in this individual with pancreatic cancer have a tremendous impact on not only her treatment but also her [...]

Advanced molecular genetics testing delivers lung cancer treatment decision with 5-day international turnaround. An Israeli oncologist referred his 63-year-old female lung cancer patient to the personalized cancer testing expertise of CIRCULOGENE looking for a faster treatment [...]

Single-tube liquid biopsy overcomes tissue biopsy failure to give oncologist personalized treatment decision guidance in matter of days. A southeastern oncologist treating a 66-year-old male with lung cancer was unable to obtain testing results due [...]

CIRCULOGENE testing rapidly matches young patient with targeted therapy for rare non-small-cell lung cancer genetic variation. An oncologist referred a blood sample on his 44-year-old female non-small cell lung cancer (NSCLC) patient to CIRCULOGENE for [...]